21-Hydroxylase Genotyping in Australasian Patients with Congenital Adrenal Hyperplasia
- 1 January 2009
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 22 (2), 127-142
- https://doi.org/10.1515/jpem.2009.22.2.127
Abstract
Mutations in CYP21 (21-hydroxylase) lead to congenital adrenal hyperplasia (CAH). We genotyped 26 probands with CAH by PCR-sequencing the entire CYP21 gene. 25/26 had homozygous or compound heterozygous mutations. The frequencies of mutations were similar to other populations with deletion/hybrid, I2 G splice and I172N the most common. Five patients with a I172N allele predicting simple-virilising CAH had a salt-wasting phenotype. Two other probands also had a more severe phenotype than predicted by genotype. Two families had both non-classic and salt-wasting phenotypes arising from combinations of three deleterious alleles. Two novel CYP21 alleles were detected: D106N and a large deletion encompassing CYP21 and adjacent pseudogene. Two rare CYP21 alleles were also found. Three of these four novel/rare alleles were only detected as a result of sequencing the entire CYP21 gene. Entire CYP21 sequencing will increase the number of mutations detected in CAH, and in combination with functional studies should contribute a greater understanding of phenotype-genotype correlations.Keywords
This publication has 42 references indexed in Scilit:
- Congenital Adrenal Hyperplasia due to 21-Hydroxylase DeficiencyEndocrine Reviews, 2000
- Predicting Phenotype in Steroid 21-Hydroxylase Deficiency? Comprehensive Genotyping in 155 Unrelated, Well Defined Patients from Southern GermanyJournal of Clinical Endocrinology & Metabolism, 2000
- Genotyping of CYP21, Linked Chromosome 6p Markers, and a Sex-Specific Gene in Neonatal Screening for Congenital Adrenal HyperplasiaJournal of Clinical Endocrinology & Metabolism, 1999
- Population-Wide Evaluation of Disease Manifestation in Relation to Molecular Genotype in Steroid 21-Hydroxylase (CYP21) Deficiency: Good Correlation in a Well Defined PopulationJournal of Clinical Endocrinology & Metabolism, 1997
- Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestationJournal of Clinical Endocrinology & Metabolism, 1994
- Mutations in Steroid 21-Hydroxylase (CYP21)Human Mutation, 1994
- de novo mutation causes steroid 21-hydroxylase deficiency in one family of HLA-identical affected and unaffected siblingsJournal of Clinical Endocrinology & Metabolism, 1993
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorderScreening, 1993
- Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency.JCI Insight, 1992
- Genetic Mapping of the 21-Hydroxylase-Deficiency Gene within the HLA Linkage GroupThe New England Journal of Medicine, 1978